Autoimmune Disease Diagnosis Market Outlook Signals Expansion To $9.37 Billion Through 2030

The autoimmune disease diagnosis sector is on track for substantial expansion as technological advancements and personalized approaches transform how these conditions are identified. Increasing demand for precise and timely diagnostics is driving innovation and investment in this critical healthcare field. Let's explore the current market outlook, major players, emerging trends, and key segments that define this growing industry.

Expected Market Value and Growth of the Autoimmune Disease Diagnosis Industry
The autoimmune disease diagnosis market is projected to reach a valuation of $9.38 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6%. This impressive growth trajectory is fueled by several key factors, such as heightened demand for early and accurate diagnosis, broader adoption of AI-powered diagnostic analytics, and the rise of personalized diagnostic methods. In addition, increasing investments in autoimmune disease research and expanding use of point-of-care testing are playing vital roles. Noteworthy trends anticipated to influence the market include greater use of advanced immunological assays, increased reliance on autoantibody panels, integration of multiplex diagnostic platforms, growth in laboratory automation, and a sharper focus on early disease identification.

The autoimmune disease diagnosis market size has grown strongly in recent years. It will grow from $6.2 billion in 2025 to $6.74 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing prevalence of autoimmune diseases, improved availability of immunoassay technologies, expansion of clinical laboratory networks, growing physician awareness of autoimmune conditions, wider adoption of routine screening tests.

Download a free sample of the autoimmune disease diagnosis market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Primary Companies Leading the Autoimmune Disease Diagnosis Market
A number of prominent corporations stand out as leaders in this industry, including Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc, bioMérieux SA, SQI Diagnostics, Philips Healthcare India, Agappe Diagnostics Ltd, Lepu Medical Technology Company (Beijing) Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Becton dic*kinson and Company, and Ortho Clinical Diagnostics. These companies are pivotal in shaping market innovations and expanding diagnostic capabilities worldwide.

Key Trends Transforming the Autoimmune Disease Diagnosis Industry
Industry leaders are heavily investing in cutting-edge technologies like multiplex autoantibody assay platforms, which enable comprehensive and early detection of autoimmune diseases. These platforms allow simultaneous measurement of multiple disease-specific autoantibodies from a single patient sample, significantly enhancing both sensitivity and specificity compared to conventional methods such as single-analyte ELISA or immunofluorescence tests. This approach also reduces the required sample volume and shortens turnaround times, offering improved diagnostic accuracy and patient management.

View the full autoimmune disease diagnosis market report:
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

For example, in January 2025, U.S.-based diagnostics firm Exagen Inc. launched its AVISE CTD platform, incorporating novel biomarker assays for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This platform detects biomarkers such as TIgG, TIgM, and TC4d, which help clinicians more accurately differentiate overlapping autoimmune conditions. It also seamlessly integrates with existing laboratory workflows, streamlining diagnosis and enhancing clinical decision-making.

Detailed Breakdown of Autoimmune Disease Diagnosis Market Segments
This market can be analyzed through several important segments, providing insight into its diverse components:
1) By Product Category: Consumables and Assay Kits, Instruments
2) By Test Type Classification: Routine Laboratory Tests, Autoantibody Tests, Immunologic Tests, Other Tests
3) By End User Groups: Clinical Laboratories, Hospitals, Other End Users

Within these, further subdivisions exist:
- Consumables and Assay Kits include ELISA kits, reagents and test kits, sample collection and preservation devices, and control and calibration materials
- Instruments comprise immunoassay analyzers, flow cytometers, luminometers, and microscopes

This classification helps stakeholders understand market dynamics and target areas for innovation and growth.

What's included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.